Dr. Reddy's Laboratories, Senores Pharmaceuticals Launch Ivermectin Tablets USP, 3 Mg In US Market
Dr. Reddy's Laboratories, Senores Pharmaceuticals Launch Ivermectin Tablets USP, 3 Mg In US Market
Dr. Reddy's實驗室和Senores製藥公司推出美國市場的伊維菌素片，3毫克
Dr. Reddy's Laboratories, Inc. and Senores Pharmaceuticals, Inc. today announced the launch of Ivermectin Tablets USP, 3 mg, which is bioequivalent and therapeutically equivalent to STROMECTOL Tablets of Merck Sharp and Dohme LLC in the U.S. market. The product will be marketed by Dr. Reddy's.
Dr. Reddy's實驗室和Senores製藥公司今日宣佈推出伊維菌素片3毫克，該產品與美國市場上的默沙東的Stromectol片劑在生物等效性和治療等效性上相等。該產品將由Dr. Reddy's進行市場推廣。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間